This molecular panel identifies common viral and bacterial pathogens causing upper respiratory infections — including influenza, RSV, parainfluenza, adenovirus, rhinovirus, certain bacteria like Streptococcus and Mycoplasma, and SARS-CoV-2. Identifying the specific cause guides treatment, including antiviral medications, antibiotics, and infection control measures.
This test is used in evaluation of upper respiratory symptoms, particularly in vulnerable populations or when initial empiric treatment fails. Sample type is a nasopharyngeal swab.
We are CLIA certified, the highest level of Medical industry compliance and standards.
Book an appointment